In a shocking revelation, former President Bill Clinton and his Clinton Health Access Initiative (CHAI) gave away "watered-down" HIV/AIDs drugs to patients in sub-Saharan Africa, The Daily Caller reports.



The congressional report, which was titled, "The Clinton Foundation and The India Success Story," also highlighted that the drugs "likely increased" the risks of morbidity and mortality, the Daily Caller News Foundation said.

According to the report, the investigation was initiated by Rep. Marsha Blackburn, a Tennessee Republican and vice-chair of the House Energy and Commerce Committee.

The congressional report also focused on Clinton's lengthy relationship with Ranbaxy, a tainted Indian drug manufacturer, which CHAI ties up with as one of its main distributors of HIV/AIDS drugs to Third World countries.

The CHAI program is considered one of the Clinton Foundation's most important contributions as it has worked to prevent spread of HIV infections and offer treatment for children, the Washington Examiner reports.

The report also highlighted the role of former Ranbaxy employee Dinesh Thakur, who became a whistleblower, encouraging the U.S. government to pursue a lawsuit against the Indian pharmaceutical firm. Because the company sold its generic drugs in the U.S. market, it was vulnerable to the country's prosecution.

In 2013, Ranbaxy pleaded guilty in seven criminal counts for introducing adulterated drugs into interstate commerce.

The Justice Department then levied a $500 million fine and forfeiture on the company.

"This is the largest false claims case ever prosecuted in the District of Maryland, and the nation's largest financial penalty paid by a generic pharmaceutical company," the U.S. Attorney for the District of Maryland Rod J. Rosenstein said when Ranbaxy pled guilty.

In its final statement, the Justice Department stated that due to the company's diluted drugs, it 'subjected patients to increased risks of morbidity and mortality,' according to the report.